Publications

Article

The Business Case for Investing in Physician Well-Being

By: Tait D. Shanafelt, Joel Goh and Christine A. Sinsky

Importance: Widespread burnout among physicians has been recognized for more than two decades. Extensive evidence indicates that physician burnout has important personal and professional consequences.
Observations: A lack of awareness regarding... View Details

Keywords: Physicians; Well-being; ROI; Health; Welfare or Wellbeing; Ethics; Investment Return; Health Industry

Find at Harvard

Article

A Feasibility Study Using Time-driven Activity-based Costing as a Management Tool for Provider Cost Estimation: Lessons from the National TB Control Program in Zimbabwe in 2018

By: J. Chirenda, B. Nhlema Simwaka, C. Sandy, K. Bodnar, S. Corbin, P. Desai, T. Mapako, S. Shamu, C. Timire, E. Antonio, A. Makone, A. Birikorang, T. Mapuranga, M. Ngwenya, T. Masunda, M. Dube, E. Wandwalo, L. Morrison and R. S. Kaplan

Background: This study used process maps and time-driven activity-based costing to document TB service delivery processes. The analysis identified the resources required to sustain TB services in Zimbabwe, as well as several opportunities for more effective and... View Details

Keywords: Time-Driven Activity-Based Costing; Provider Cost; Health Care and Treatment; Cost Management; Activity Based Costing and Management; Zimbabwe

Read Now

June 2003 (Revised May 2006)
Case

Cipla

By: Rohit Deshpande and Laura Winig

The head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line... View Details

Keywords: Trade; Price; Global Strategy; Health Care and Treatment; Patents; Leadership; Marketing Strategy; Health Industry; South Africa; India

12 Jul 2016
First Look

July 12, 2016

gaining information. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=51329 July–August 2016 Harvard Business Review How to Pay for Health Care By: Porter, Michael E., and Robert S. Kaplan Abstract—The United States stands... View Details

Keywords: Sean Silverthorne

12 Aug 2014
First Look

First Look: August 12

http://hbr.org/product/salauno-eliminating-needless-blindness-in-mexico/an/814041-PDF-ENG Harvard Business School Case 114-077 Building a High Performance Culture at IDFC IDFC was set up in 1997 to direct private finance to infrastructure... View Details

Keywords: Sean Silverthorne

December 2022
Article

The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies

By: Pragya Kakani, Michael Chernew and Amitabh Chandra

Context: To what extent does pharmaceutical revenue growth depend on new medicines versus increasing prices for existing medicines? Moreover, does using list prices, as is commonly done, instead of prices net of confidential rebates offered by manufacturers, which are... View Details

Keywords: Revenue; Price; Policy; Business Strategy; Pharmaceutical Industry

Find at Harvard

19 Jul 2017
Research & Ideas

Why Government 'Nudges' Motivate Good Citizen Behavior

Milkman, among others, the group settled on four areas of particular interest to nudge units in the United States and United Kingdom—retirement savings, college enrollment, public health interventions, and energy consumption. They then... View Details

Keywords: by Michael Blanding

15 Dec 2023
News

Like-Minded

connect with one another along the way. Murakami was with OECD Tokyo Center, leading discussions on economic policy issues with government and business leaders in Asia, having spent 20 years in finance with companies like Goldman Sachs... View Details

02 Sep 2014
First Look

First Look: September 2

legacy labor and health care costs-is seriously incomplete and that GM's share collapsed for many of the same reasons that many of the other highly successful American firms of the 50s, 60s, and 70s were forced from the market, including... View Details

Keywords: Sean Silverthorne

Web

Globalization - Faculty & Research

demanding than what the minimalist nature of duties of forbearance initially would suggest. 2014 Working Paper Finance and Social Responsibility in the Informal Economy: Institutional Voids, Globalization and Microfinance Institutions By:... View Details

31 Oct 2023
News

Securing a Resilient Future for Senegal

largest in Africa second to South Africa. Senegal was one of the first African countries to come up with a resiliency plan. It included all the necessary health support for patient treatment and contact tracing, including procurement of... View Details

January 2023
Case

Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery

By: Regina Herzlinger and Brian Walker

What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details

Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry

May 21, 2020
Editorial

Primary Care Is Hurting: Why Aren't Private Insurers Pitching In?

By: Leemore S. Dafny and J. Michael McWilliams

Primary care clinicians are the front line for patients with suspected infection. We rely on them to diagnose, triage, and manage patients with potential or confirmed COVID infections. They are also responsible for keeping non-COVID medical conditions under control... View Details

Keywords: COVID-19; Primary Care; Health Pandemics; Health Care and Treatment; Financial Condition; Insurance

Read Now

January 2021 (Revised May 2021)
Case

Delta Air Lines: Navigating the COVID-19 Storm

By: Ted Berk and Ryan Flamerich

This case examines Delta Air Lines’ response as demand for its services plummeted in the face of the COVID-19 pandemic, with a focus on the company’s funding needs and capital structure. Following a series of initial actions, the company’s cash “burn” had reduced from... View Details

Keywords: COVID-19; Health Pandemics; Financial Condition; Capital Structure; Crisis Management; Risk Management; Business and Stakeholder Relations; Air Transportation Industry

November 2020
Teaching Note

Valuing Celgene's CVR

By: Benjamin C. Esty and Daniel Fisher

Teaching Note for HBS Case No. 221-031. When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA)... View Details

Keywords: Mergers and Acquisitions; Valuation; Value; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Pharmaceutical Industry; Biotechnology Industry; United States

04 Apr 2024
News

The Making of a Medical Milestone

trial in ALS as well. We recently spoke with Dr. Gros, Eledon’s founder and CEO, about tegoprubart’s potential to revolutionize transplant medicine, why he left medicine to become a serial health care entrepreneur, and what drives his... View Details

Keywords: Margie Kelley

January 2024
Article

A Cost Model for a Low Threshold Clinic Treating Opioid Use Disorder

By: Sarah E. Wakeman, Elizabeth Powell, Syed Shehab, Grace Herman, Laura Kehoe and Robert S. Kaplan

The US fee-for-service payment system under-reimburses clinics offering access to comprehensive treatments for opioid use disorder (OUD). The funding shortfall limits a clinic’s ability to expand and improve access, especially for socially marginalized patients with... View Details

Keywords: Health Care and Treatment; Cost; Equality and Inequality; Health Industry

Find at Harvard